Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

FHS
June 13, 2024
1:13 pm

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 | Psychedelic Invest

VANCOUVER, BC, July 10, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioural health

July 11, 2024

Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit – Biotech Investments

EQS-News: Medios AG / Key word(s): Contract Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit 01.02.2024

February 6, 2024

AstraZeneca unveils positive Phase 3 data to move Imfinzi into earlier stages of lung cancer

AstraZeneca is moving its blockbuster cancer drug Imfinzi into earlier stages of small cell lung cancer, a disease that has not seen innovation in standard

April 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.